ZBIO
Zenas BioPharma, Inc. Common Stock
NASDAQ: ZBIO · HEALTHCARE · BIOTECHNOLOGY
$17.55
-2.55% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
—
P/S ratio
109.46x
EPS (TTM)
$-8.44
Dividend yield
—
52W range
$9 – $45
Volume
0.7M
Zenas BioPharma, Inc. Common Stock (ZBIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-2,114.00%
ROE
-136.20%
ROA
-35.10%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-119.28M | — | — | — |
| 2023 | $50.00M | $-37.12M | 100.00% | -74.29% | -74.25% |
| 2024 | $5.00M | $-156.99M | -2,682.78% | -3,277.76% | -3,139.76% |
| 2025 | $10.00M | $-377.74M | 99.44% | -2,113.85% | -3,777.37% |